169 related articles for article (PubMed ID: 11374028)
1. Transforming growth factor-betas and CD105 expression in calcification and bone formation in human atherosclerotic lesions.
Jeziorska M
Z Kardiol; 2001; 90 Suppl 3():23-6. PubMed ID: 11374028
[TBL] [Abstract][Full Text] [Related]
2. Endoglin is overexpressed after arterial injury and is required for transforming growth factor-beta-induced inhibition of smooth muscle cell migration.
Ma X; Labinaz M; Goldstein J; Miller H; Keon WJ; Letarte M; O'Brien E
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2546-52. PubMed ID: 11116051
[TBL] [Abstract][Full Text] [Related]
3. TNF alpha down-regulates CD105 expression in vascular endothelial cells: a comparative study with TGF beta 1.
Li C; Guo B; Ding S; Rius C; Langa C; Kumar P; Bernabeu C; Kumar S
Anticancer Res; 2003; 23(2B):1189-96. PubMed ID: 12820370
[TBL] [Abstract][Full Text] [Related]
4. Endoglin, a TGF-beta receptor-associated protein, is expressed by smooth muscle cells in human atherosclerotic plaques.
Conley BA; Smith JD; Guerrero-Esteo M; Bernabeu C; Vary CP
Atherosclerosis; 2000 Dec; 153(2):323-35. PubMed ID: 11164421
[TBL] [Abstract][Full Text] [Related]
5. Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-beta in fibrofatty lesion development.
Bobik A; Agrotis A; Kanellakis P; Dilley R; Krushinsky A; Smirnov V; Tararak E; Condron M; Kostolias G
Circulation; 1999 Jun; 99(22):2883-91. PubMed ID: 10359732
[TBL] [Abstract][Full Text] [Related]
6. Ossification in atherosclerotic carotid arteries.
Deneke T; Langner K; Grewe PH; Harrer E; Müller KM
Z Kardiol; 2001; 90 Suppl 3():106-15. PubMed ID: 11374022
[TBL] [Abstract][Full Text] [Related]
7. Significant expression of endoglin (CD105), TGFbeta-1 and TGFbeta R-2 in the atherosclerotic aorta: an immunohistological study.
Piao M; Tokunaga O
J Atheroscler Thromb; 2006 Apr; 13(2):82-9. PubMed ID: 16733295
[TBL] [Abstract][Full Text] [Related]
8. Expression and structural features of endoglin (CD105), a transforming growth factor beta1 and beta3 binding protein, in human melanoma.
Altomonte M; Montagner R; Fonsatti E; Colizzi F; Cattarossi I; Brasoveanu LI; Nicotra MR; Cattelan A; Natali PG; Maio M
Br J Cancer; 1996 Nov; 74(10):1586-91. PubMed ID: 8932339
[TBL] [Abstract][Full Text] [Related]
9. Synergy between anti-endoglin (CD105) monoclonal antibodies and TGF-beta in suppression of growth of human endothelial cells.
She X; Matsuno F; Harada N; Tsai H; Seon BK
Int J Cancer; 2004 Jan; 108(2):251-7. PubMed ID: 14639611
[TBL] [Abstract][Full Text] [Related]
10. CD105 (endoglin) expression on hematopoietic stem/progenitor cells.
Pierelli L; Bonanno G; Rutella S; Marone M; Scambia G; Leone G
Leuk Lymphoma; 2001; 42(6):1195-206. PubMed ID: 11911400
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of neovascularisation in atherosclerotic plaques using CD31, CD105 and TGF beta 1.
Li C; Mollahan P; Baguneid MS; McMahon RF; Kumar P; Walker MG; Freemont AJ; Kumar S
Pathobiology; 2006; 73(4):192-7. PubMed ID: 17119348
[TBL] [Abstract][Full Text] [Related]
12. TGF-{beta} signaling of human T cells is modulated by the ancillary TGF-{beta} receptor endoglin.
Schmidt-Weber CB; Letarte M; Kunzmann S; Rückert B; Bernabéu C; Blaser K
Int Immunol; 2005 Jul; 17(7):921-30. PubMed ID: 15967783
[TBL] [Abstract][Full Text] [Related]
13. Functional role of CD105 in TGF-beta1 signalling in murine and human endothelial cells.
Warrington K; Hillarby MC; Li C; Letarte M; Kumar S
Anticancer Res; 2005; 25(3B):1851-64. PubMed ID: 16158917
[TBL] [Abstract][Full Text] [Related]
14. Regulation of vascular calcification in atherosclerosis.
Parhami F; Tintut Y; Patel JK; Mody N; Hemmat A; Demer LL
Z Kardiol; 2001; 90 Suppl 3():27-30. PubMed ID: 11374029
[TBL] [Abstract][Full Text] [Related]
15. Differential expression and cytoplasm/membrane distribution of endoglin (CD105) in human tumour cell lines: Implications in the modulation of cell proliferation.
Postiglione L; Di Domenico G; Caraglia M; Marra M; Giuberti G; Del Vecchio L; Montagnani S; Macri M; Bruno EM; Abbruzzese A; Rossi G
Int J Oncol; 2005 May; 26(5):1193-201. PubMed ID: 15809709
[TBL] [Abstract][Full Text] [Related]
16. Endoglin is a component of the transforming growth factor (TGF)-beta receptor complex of human pre-B leukemic cells.
Zhang H; Shaw AR; Mak A; Letarte M
J Immunol; 1996 Jan; 156(2):564-73. PubMed ID: 8543807
[TBL] [Abstract][Full Text] [Related]
17. Endoglin expression on human microvascular endothelial cells association with betaglycan and formation of higher order complexes with TGF-beta signalling receptors.
Wong SH; Hamel L; Chevalier S; Philip A
Eur J Biochem; 2000 Sep; 267(17):5550-60. PubMed ID: 10951214
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques.
Cipollone F; Fazia M; Mincione G; Iezzi A; Pini B; Cuccurullo C; Ucchino S; Spigonardo F; Di Nisio M; Cuccurullo F; Mezzetti A; Porreca E
Stroke; 2004 Oct; 35(10):2253-7. PubMed ID: 15297631
[TBL] [Abstract][Full Text] [Related]
19. Relationship between expression of CD105 and growth factors in malignant tumors of gastrointestinal tract and its significance.
Yu JX; Zhang XT; Liao YQ; Zhang QY; Chen H; Lin M; Kumar S
World J Gastroenterol; 2003 Dec; 9(12):2866-9. PubMed ID: 14669355
[TBL] [Abstract][Full Text] [Related]
20. Differential kinetics of plasma CD105 and transforming growth factor beta expression early in human acute pancreatitis.
Jamdar S; Al-Mowallad AF; Kumar S; Siriwardena AK
Pancreas; 2006 Mar; 32(2):152-8. PubMed ID: 16552334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
